Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating income | — | -$4.57M | -$65.1M | -$54.1M | -$143M | -$245M |
| Net income | — | -$4.54M | -$50.0M | -$36.0M | -$119M | -$227M |
| EPS (diluted) | — | -$0.31 | -$1.70 | -$0.73 | -$1.89 | -$3.53 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | — | -$611K | -$55.9M | -$42.8M | -$117M | -$196M |
| Capital expenditures | — | — | $16.0K | $284K | $520K | $35.0K |
| Free cash flow | — | — | -$55.9M | -$43.1M | -$117M | -$196M |
| Share buybacks | — | — | $0.00 | $0.00 | $50.00 | — |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.34M | $8.04M | $39.5M | $451M | $180M | $335M |
| Total assets | $117M | $9.68M | $76.8M | $527M | $478M | $424M |
| Total liabilities | $4.15M | $21.3M | $8.08M | $13.0M | $24.5M | $120M |
| Long-term debt | — | — | — | — | $0.00 | $74.1M |
| Shareholders' equity | -$2.52M | -$11.6M | $48.9M | $496M | $447M | $304M |
| Retained earnings | -$2.52M | -$53.6M | -$80.7M | -$117M | -$236M | -$463M |
| Shares (wtd avg diluted) | — | 360M | 29.4M | 49.1M | 62.9M | 64.5M |
Every figure is extracted from MoonLake Immunotherapeutics’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.